Evidence map›Paper›PMID 40596983›Full record

ArticleBMC medical research methodology2025

Extended sample size calculations for evaluation of prediction models using a threshold for classification.

Rebecca Whittle, Joie Ensor, Lucinda Archer, Gary S Collins, Paula Dhiman, Alastair Denniston, Joseph Alderman, Amardeep Legha, Maarten van Smeden, Karel G Moons and 3 more

Abstract read
In one paragraph

Article in BMC medical research methodology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rebecca WhittleDepartment of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK. r.l.whittle@bham.ac.uk.
Joie EnsorDepartment of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.
Lucinda ArcherDepartment of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.
Gary S CollinsCentre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.
Paula DhimanCentre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.
Alastair DennistonNational Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, UK.
Joseph AldermanNational Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, UK.
Amardeep LeghaDepartment of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.
Maarten van SmedenJulius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Karel G MoonsJulius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Jean-Baptiste CazierFrancis Crick Institute, London, UK.
Richard D Riley *Department of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.
Kym I E Snell *Department of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.

Funding

Cancer Research UK C49297/A27294Cancer Research UK PRCPJT-Nov21\100021Engineering and Physical Sciences Research Council EP/Y018516/1
6 · The paper itself

Abstract

When evaluating the performance of a model for individualised risk prediction, the sample size needs to be large enough to precisely estimate the performance measures of interest. Current sample size guidance is based on precisely estimating calibration, discrimination, and net benefit, which should be the first stage of calculating the minimum required sample size. However, when a clinically important threshold is used for classification, other performance measures are also often reported. We extend the previously published guidance to precisely estimate threshold-based performance measures. We have reported closed-form solutions to estimate the sample size required to target sufficiently precise estimates of accuracy, specificity, sensitivity, positive predictive value (PPV), negative predictive value (NPV), and an iterative method to estimate the sample size required to target a sufficiently precise estimate of the F1-score, in an external evaluation study of a prediction model with a binary outcome. This approach requires the user to pre-specify the target standard error and the expected value for each performance measure alongside the outcome prevalence. We describe how the sample size formulae were derived and demonstrate their use in an example. Extension to time-to-event outcomes is also considered. In our examples, the minimum sample size required was lower than that required to precisely estimate the calibration slope, and we expect this would most often be the case. Our formulae, along with corresponding Python code and updated R, Stata and Python commands (pmvalsampsize), enable researchers to calculate the minimum sample size needed to precisely estimate threshold-based performance measures in an external evaluation study. These criteria should be used alongside previously published criteria to precisely estimate the calibration, discrimination, and net-benefit.

Indexed as

Models, StatisticalAlgorithmsHumansPredictive Value of TestsRisk AssessmentSample SizeSensitivity and SpecificityClassification modelsClinical prediction modelsExternal validationModel evaluationPerformance measuresSample sizeThreshold

Identifiers

PMID40596983
PMCPMC12210805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.